BOSTON–(BUSINESS WIRE)–Foundation Medicine’s molecular residual disease (MRD) assay, FoundationOne®MRD, has been named a 2026 Top Innovation by The Scientist.

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.